Amount of HIV DNA in peripheral blood mononuclear cells is proportional to the severity of HIV-1-associated neurocognitive disorders

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 21, Issue 1, 2009, Pages 68-74

  Shiramizu, Bruce ^a,c   Williams, Andrew E ^b   Shikuma, Cecilia ^a   Valcour, Victor ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b Kaiser Foundation Hospitals   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR CLINICAL STUDY; NEUROPSYCHIATRY; NEUROPSYCHOLOGICAL TEST; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS LOAD;

EID: 64849115312     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2009.21.1.68     Document Type: Article

References (44)

1. Sacktor N, McDermott MP, Marder K, et al: HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 2002; 8:136-142
2. Anderson E, Zink W, Xiong H, et al: HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J Acquir Immune Defic Syndr 2002; 31(suppl 2):S43-54
3. Gartner S: HIV infection and dementia. Science 2000; 287:602- 604
4. Major EO, Rausch D, Marra C, et al: HIV-associated dementia. Science 2000; 288:440-442
5. McArthur JC, Sacktor N, Selnes O: Human immunodeficiency virus-associated dementia. Semin Neurol 1999; 19:129-150
6. Neuenburg JK, Brodt HR, Herndier BG, et al: HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 31:171-177
7. Pulliam L, Gascon R, Stubblebine M, et al: Unique monocyte subset in patients with aids dementia. Lancet 1997; 349:692-695
8. Fischer-Smith T, Croul S, Sverstiuk AE, et al: CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J Neurovirol 2001; 7:528-541
9. Robertson K, Fiscus S, Kapoor C, et al: CSF, plasma viral load and HIV associated dementia. J Neurovirol 1998; 4:90-94
10. De Luca A, Ciancio BC, Larussa D, et al: Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals. Neurology 2002; 59:342-347
11. Ellis RJ, Hsia K, Spector SA, et al: Cerebrospinal fluid human immunodeficiency virus type 1. RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Res Center Group Ann Neurol 1997; 42:679-688
12. Reger MA, Martin DJ, Cole SL, et al: The relationship between plasma viral load and neuropsychological functioning in HIV-1 infection. Arch Clin Neuropsychol 2005; 20:137-143
13. Cysique LA, Maruff P, Brew BJ: Prevalence and pattern of neuropsychological impairment in human immunodeficiency virusinfected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. J Neurovirol 2004; 10:350-357
14. Langford TD, Letendre SL, Larrea GJ, et al: Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathol 2003; 13:195-210
15. Albright AV, Soldan SS, Gonzalez-Scarano F: Pathogenesis of human immunodeficiency virus-induced neurological disease. J Neurovirol 2003; 9:222-227
16. McArthur JC, Haughey N, Gartner S, et al: Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol 2003; 9:205-221
17. Lawrence DM, Major EO: HIV-1 and the brain: connections between HIV-1-associated dementia, neuropathology, and neuroimmunology Microbes Infect 2002; 4:301-308
18. Donovan RM, Dickover RE, Goldstein E, et al: HIV-1 proviral copy number in blood mononuclear cells from aids patients on zidovudine therapy. J Acquir Immune Defic Syndr 1991; 4:766- 769
19. Russell RR, Bowmer MI, Nguyen C, et al: HIV-1. DNA burden in peripheral blood CD4 + cells influences disease progression, antiretroviral efficacy, and CD4+ T-cell restoration. Viral Immunol 2001; 14:379-389
20. Zhao Y, Yu M, Miller JW, et al: Quantification of human immunodeficiency virus type 1 proviral DNA by using taqman technology. J Clin Microbiol 2002; 40:675-678
21. Wood R, Dong H, Katzenstein DA, et al: Quantification and comparison of HIV-1 proviral load in peripheral blood mononuclear cells and isolated CD4+ T cells. J Acquir Immune Defic Syndr 1993; 6:237-240
22. Shiramizu B, Gartner S, Williams A, et al: Circulating proviral HIV DNA and HIV-associated dementia. Aids 2005; 19:45-52
23. Bruisten SM, Reiss P, Loeliger AE, et al: Cellular proviral HIV type 1. DNA load persists after long-term RT-inhibitor therapy in HIV type 1 infected persons. AIDS Res Hum Retroviruses 1998; 14:1053-1058
24. Delobel P, Sandres-Saune K, Cazabat M, et al: Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4. T cells during prolonged suppressive HAART. Aids 2005; 19:1739-1750
25. Dickover RE, Donovan RM, Goldstein E, et al: Decreases in unintegrated HIV DNA are associated with antiretroviral therapy in aids patients. J Acquir Immune Defic Syndr 1992; 5:31-36
26. Shiramizu B, Ratto-Kim S, Sithinamsuwan P, et al: HIV DNA and dementia in treatment-naive HIV-1-infected individuals in Bangkok, Thailand. Int J Med Sci 2006; 4:13-18
27. Shiramizu B, Paul R, Williams A, et al: HIV proviral DNA associated with decreased neuropsychological function. J Neuropsychiatry Clin Neurosci 2007; 19:157-163
28. Stern Y, McDermott MP, Albert S, et al: Factors associated with incident human immunodeficiency virus-dementia. Arch Neurol 2001; 58:473-479
29. Larussa D, Lorenzini P, Cingolani A, et al: Highly active antiretroviral therapy reduces the age-associated risk of dementia in a cohort of older HIV-1-infected patients. AIDS Res Hum Retroviruses 2006; 22:386-392
30. Valcour VG, Sacktor NC, Paul RH, et al: Insulin resistance is associated with cognition among HIV-1-infected patients: the Hawaii Aging with HIV cohort. J Acquir Immune Defic Syndr 2006; 43:405-410
31. Valcour VG, Shikuma CM, Watters MR, et al: Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms. AIDS 2004; 18:S79-86
32. Valcour V, Shikuma C, Shiramizu B, et al: Higher frequency of dementia in older HIV + individuals. The Hawaii Aging with HIV cohort. Neurol 2004; 63:822-827
33. Grassi MP, Perin C, Clerici F, et al: Neuropsychological performance in HIV-1-infected drug abusers. Acta Neurol Scand 1993; 88:119-122
34. Portegies P, Enting RH, de Gans J, et al: Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam. Aids 1993; 7:669-675
35. Dougherty RH, Skolasky RL Jr, McArthur JC: Progression of HIV-associated dementia treated with HAART. AIDS Read 2002; 12:69-74
36. Shiramizu B, Gartner S, Williams A, et al: Correlation of Circulating Proviral HIV DNA and with HIV-Associated Dementia. AIDS (in press)
37. Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders. Neurology 1996; 47:1247-1253
38. Concha M, Selnes OA, McArthur JC, et al: Normative data for a brief neuropsychologic test battery in a cohort of injecting drug users. Int J Addict 1995; 30:823-841
39. Heaton RK, Avitable N, Grant I, et al: Further crossvalidation of regression-based neuropsychological norms with an update for the Boston naming test. J Clin Exp Neuropsychol 1999; 21:572- 582
40. Tombaugh TN, Kozak J, Rees L: Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol 1999; 14:167-177
41. Chiulli S, Haaland K, LaRue A, et al: Impact of age on drawing the Rey-Osterrieth figure. The Clin Neuropsychologist 1995; 9:219-224
42. Robbins R, Rivera Mindt M, Heaton RK, et al: Are there ethnicity differences in the ability of neuropsychological test performance to predict functional impairment in HIV infection? in Thirty- Second Annual International Neuropsychological Society Conference. Baltimore, 2004
43. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 1991; 41:778-785
44. Shiramizu B, Gartner S, Cho M, et al: Assessment of HIV-1. DNA copies per cell by real-time polymerase chain reaction. Frontiers in Bioscience 2004; 9:255-261